Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

The Breast International Group (BIG) 1-98 study is a four-arm trial comparing 5 years of monotherapy with tamoxifen or with letrozole or with sequences of 2 years of one followed by 3 years of the other for postmenopausal women with endocrine-responsive early invasive breast cancer. From 1998 to 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Regan, Meredith M, Price, Karen N, Giobbie-Hurder, Anita, Thürlimann, Beat, Gelber, Richard D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218925/
https://www.ncbi.nlm.nih.gov/pubmed/21635709
http://dx.doi.org/10.1186/bcr2837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218925/
https://www.ncbi.nlm.nih.gov/pubmed/21635709
http://dx.doi.org/10.1186/bcr2837

Ejemplares similares